Wayne L. Furman, MD | Authors

CALIFORNIA NUTRIENTS INC

Articles

Extending Principles Learned in Model Systems to Clinical Trials Design

August 01, 1998

Clinical results with irinotecan (CPT-11 [Camptosar]) and other camptothecin derivatives in various cancers, although encouraging, have fallen short of the expectations predicted by preclinical models. One proposed